Healthtech Startups

A biopharmaceutical company with over 30 years of experience developing and commercializing treatments for central nervous system (CNS) diseases. It maintains a pipeline of product candidates supported by internal research and development.

3 investors

Adaptive is an AI-native healthcare provider that delivers home health services by combining artificial intelligence-driven operations with in-home clinicians to improve patient outcomes and reduce hospital readmissions.

3 investors

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.

3 investors

Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team. Its work centers on drug discovery and portfolio development in the life sciences.

3 investors

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier. It serves the oncology and cancer care market.

3 investors

Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.

3 investors

Advantice is a collective of skin care brands offering science-backed dermatological and wellness products for consumers seeking healthier skin. The company operates multiple trusted consumer brands focused on skin health and personal care.

3 investors

Aegis provides a platform to healthcare providers and hospitals that automates insurance denial appeals and resubmissions to recover lost revenue. The system prioritizes denials by financial impact and overturn likelihood, and integrates with major EHRs and insurance providers.

3 investors

Aegle Therapeutics develops therapies using extracellular vesicles (EVs) isolated from mesenchymal stem cells to deliver therapeutic biomolecules to diseased and damaged cells. Its lead product, AGLE-102, targets dystrophic epidermolysis bullosa, a rare pediatric skin-blistering disease, with potential applications across dermatology, immunology, and protein-deficiency disorders.

3 investors

Aethon provides autonomous mobile robots and fleet management software for facility operations, offering comprehensive support including installation, maintenance, and 24/7 monitoring for healthcare, logistics, and other enterprise environments.

3 investors

Affera develops a medical technology platform for treating cardiac arrhythmias, including atrial fibrillation, using innovative ablation solutions. The company serves cardiac electrophysiology specialists and healthcare systems treating arrhythmia patients.

3 investors

Africa Healthcare Network operates a dialysis treatment chain across Sub-Saharan Africa, delivering high-quality kidney disease care at accessible prices. The company combines clinical expertise with operational experience suited to resource-limited healthcare markets in the region.

3 investors

Agamon Health builds data platforms that transform clinical data into actionable insights for healthcare providers and institutions. The company serves doctors, hospitals, and the healthcare industry by simplifying medical reporting processes.

3 investors

Agapé is a mobile app designed to strengthen romantic relationships through daily personalized questions that spark meaningful conversation between couples. The app uses machine learning to tailor questions to users' preferences and offers both free and premium subscription tiers.

3 investors

Agios is a biopharmaceutical company developing therapies for rare diseases, with a primary focus on hemolytic anemias including pyruvate kinase deficiency, thalassemia, and sickle cell disease. The company's approach is grounded in cellular metabolism research and involves close collaboration with patients and clinical partners.

3 investors

Ahammune develops therapeutic treatments for chronic skin diseases with unmet medical need. The company aims to address dermatological disorders through scientific innovation and comprehensive treatment strategies.

3 investors

AiD Medical develops health technologies, including AI and machine learning tools, aimed at improving health outcomes across the Global South.

3 investors

Kaia Health develops digital therapeutic programs for chronic pain management and COPD, serving enterprise companies, health plans, and health systems primarily in the US and Europe. The platform delivers clinically-guided exercise and mind-body therapy accessible via digital channels.

3 investors

Aidaly operates a software-powered home care agency that trains and pays family members to provide long-term care for their relatives, helping families navigate eligibility programs and reduce system barriers. It serves family caregivers in the United States, currently operating in South Florida, Arizona, Michigan, and Colorado.

3 investors

Aidin provides data analytics and workflow optimization software for healthcare providers to improve patient flow and reduce delays in post-acute care transitions across hospital systems.

3 investors

AIM Biotech develops organ-on-chip and 3D tissue culture platforms (idenTx, organiX, and Avatar) for drug discovery and preclinical research. The company provides tools for academic and pharmaceutical researchers to model human tissue microenvironments and accelerate therapeutic development.

3 investors

Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.

3 investors

Airfinity provides AI-powered predictive analytics, simulation, and forecasting for the life sciences industry, focused on medicine and vaccine demand forecasting across specific disease areas. It serves biopharma companies, governments, and global health organisations to support decision-making.

3 investors

Aitia builds in silico models of human disease biology using a causal AI platform that combines multiomic and clinical patient data with supercomputing to support drug discovery and development. It partners with biopharma companies to identify novel drug targets across diseases such as oncological, neurodegenerative, immunological, and cardiometabolic conditions.

3 investors